Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Eukaryot Microbiol ; 63(5): 598-609, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26909872

RESUMEN

Glycerolipids are the main constituents of biological membranes in Trypanosoma brucei, which causes sleeping sickness in humans. Importantly, they occur as a structural component of the glycosylphosphatidylinositol lipid anchor of the abundant cell surface glycoproteins procyclin in procyclic forms and variant surface glycoprotein in bloodstream form, that play crucial roles for the development of the parasite in the insect vector and the mammalian host, respectively. The present work reports the characterization of the glycerol-3-phosphate acyltransferase TbGAT that initiates the biosynthesis of ester glycerolipids. TbGAT restored glycerol-3-phosphate acyltransferase activity when expressed in a Leishmania major deletion strain lacking this activity and exhibited preference for medium length, unsaturated fatty acyl-CoAs. TbGAT localized to the endoplasmic reticulum membrane with its N-terminal domain facing the cytosol. Despite that a TbGAT null mutant in T. brucei procyclic forms lacked glycerol-3-phosphate acyltransferase activity, it remained viable and exhibited similar growth rate as the wild type. TbGAT was dispensable for the biosynthesis of phosphatidylcholine, phosphatidylinositol, phosphatidylserine, and GPI-anchored protein procyclin. However, the null mutant exhibited a slight decrease in phosphatidylethanolamine biosynthesis that was compensated with a modest increase in production of ether phosphatidylcholine. Our data suggest that an alternative initial acyltransferase takes over TbGAT's function in its absence.


Asunto(s)
Membrana Celular/metabolismo , Glicerol-3-Fosfato O-Aciltransferasa/metabolismo , Lípidos/biosíntesis , Trypanosoma brucei brucei/enzimología , Trypanosoma brucei brucei/metabolismo , Aciltransferasas/genética , Aciltransferasas/metabolismo , Animales , Membrana Celular/química , ADN Protozoario/genética , Activación Enzimática , Pruebas de Enzimas , Glicerol-3-Fosfato O-Aciltransferasa/genética , Metabolismo de los Lípidos , Lípidos/química , Glicoproteínas de Membrana/metabolismo , Mutación , Fosfatos/metabolismo , Fosfatidilcolinas/metabolismo , Fosfatidiletanolaminas/biosíntesis , Fosfatidiletanolaminas/metabolismo , Fosfatidilinositoles/metabolismo , Fosfatidilserinas/metabolismo , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , ARN Ribosómico 18S/genética , Trypanosoma brucei brucei/genética
2.
Pharmacogenomics ; 23(5): 315-325, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35230160

RESUMEN

Background:Plasmodium vivax malaria is endemic in Madagascar, where populations have genetic inheritance from Southeast Asia and East Africa. Primaquine, a drug of choice for vivax malaria, is metabolized principally via CYP2D6. CYP2D6 variation was characterized by locus-specific gene sequencing and was compared with TaqMan™ genotype data. Materials & methods: Long-range PCR amplicons were generated from 96 Malagasy samples and subjected to next-generation sequencing. Results: The authors observed high concordance between TaqMan™-based CYP2D6 genotype calls and the base calls from sequencing. In addition, there are new variants and haplotypes present in the Malagasy. Conclusion: Sequencing unique admixed populations provides more detailed and accurate insights regarding CYP2D6 variability, which may help optimize primaquine treatment across human genetic diversity.


Asunto(s)
Antimaláricos , Citocromo P-450 CYP2D6 , África , Antimaláricos/uso terapéutico , Asia , Citocromo P-450 CYP2D6/genética , Citocromo P-450 CYP2D6/metabolismo , Humanos , Proyectos Piloto , Primaquina/uso terapéutico
3.
PLoS One ; 6(11): e27802, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22114698

RESUMEN

Ether glycerolipids of Leishmania major are important membrane components as well as building blocks of various virulence factors. In L. major, the first enzyme of the ether glycerolipid biosynthetic pathway, LmDAT, is an unusual, glycosomal dihydroxyacetonephosphate acyltransferase important for parasite's growth and survival during the stationary phase, synthesis of ether lipids, and virulence. The present work extends our knowledge of this important biosynthetic enzyme in parasite biology. Site-directed mutagenesis of LmDAT demonstrated that an active enzyme was critical for normal growth and survival during the stationary phase. Deletion analyses showed that the large N-terminal extension of this initial acyltransferase may be important for its stability or activity. Further, abrogation of the C-terminal glycosomal targeting signal sequence of LmDAT led to extraglycosomal localization, did not impair its enzymatic activity but affected synthesis of the ether glycerolipid-based virulence factor lipophosphoglycan. In addition, expression of this recombinant form of LmDAT in a null mutant of LmDAT did not restore normal growth and survival during the stationary phase. These results emphasize the importance of this enzyme's compartmentalization in the glycosome for the generation of lipophosphoglycan and parasite's biology.


Asunto(s)
Aciltransferasas/metabolismo , Glicoesfingolípidos/metabolismo , Leishmania major/enzimología , Microcuerpos/metabolismo , Proteínas Recombinantes/metabolismo , Aciltransferasas/genética , Técnica del Anticuerpo Fluorescente , Leishmania major/crecimiento & desarrollo , Plásmidos/genética , Estructura Terciaria de Proteína , Proteínas Recombinantes/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA